Phase 1 studies to assess the safety, tolerability and pharmacokinetics of JTE ‐052 (a novel Janus kinase inhibitor) ointment in Japanese healthy volunteers and patients with atopic dermatitis

The Journal of Dermatology, EarlyView.

Source: The Journal of Dermatology - April 17, 2018 Category: Dermatology Authors: Hidemi Nakagawa , Osamu Nemoto , Hiroyuki Yamada , Takeshi Nagata , Noriko Ninomiya Source Type: research